9,10-phenanthrenequinone has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afrasiabi, Z; Ahmad, A; Barnes, C; Choudhury, A; Finley, K; Padhye, S; Sarkar, F; Stovall, P; Vyas, A | 1 |
1 other study(ies) available for 9,10-phenanthrenequinone and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Targeting triple negative breast cancer cells by N3-substituted 9,10-phenanthrenequinone thiosemicarbazones and their metal complexes.
Topics: Antineoplastic Agents; Breast; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Copper; Female; Humans; Models, Molecular; Phenanthrenes; Thiosemicarbazones; Triple Negative Breast Neoplasms | 2013 |